Blockade of Rapid Influx of Extracellular Zn 2+ into Nigral Dopaminergic Neurons Overcomes Paraquat-Induced Parkinson's Disease in Rats
The herbicide paraquat (PQ) has been reported to enhance the risk of developing Parkinson's disease (PD) from epidemiological studies. PQ-induced reactive oxygen species (ROS) are linked with a selective loss of nigrostriatal dopaminergic neurons. Here, we first report a unique mechanism of nig...
Gespeichert in:
Veröffentlicht in: | Molecular neurobiology 2019-06, Vol.56 (6), p.4539 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 6 |
container_start_page | 4539 |
container_title | Molecular neurobiology |
container_volume | 56 |
creator | Tamano, Haruna Morioka, Hiroki Nishio, Ryusuke Takeuchi, Azusa Takeda, Atsushi |
description | The herbicide paraquat (PQ) has been reported to enhance the risk of developing Parkinson's disease (PD) from epidemiological studies. PQ-induced reactive oxygen species (ROS) are linked with a selective loss of nigrostriatal dopaminergic neurons. Here, we first report a unique mechanism of nigrostriatal dopaminergic degeneration, in which rapid intracellular Zn
dysregulation via PQ-induced ROS production causes PD in rats. When the substantia nigra pars compacta (SNpc) of rats was perfused with PQ, extracellular concentrations of glutamate and Zn
were increased and decreased, respectively, in the SNpc. These changes were ameliorated by co-perfusion with Trolox, an antioxidative agent. In in vitro slice experiments, PQ rapidly increased extracellular Zn
influx via AMPA receptor activation. Both loss of nigrostriatal dopaminergic neurons and increase in turning behavior in response to apomorphine were markedly reduced by coinjection of PQ and intracellular Zn
chelator, i.e., ZnAF-2DA into the SNpc. Furthermore, loss of nigrostriatal dopaminergic neurons induced with a low dose of PQ, which did not induce any behavioral abnormality, was completely blocked by coinjection of ZnAF-2DA. The present study indicates that rapid influx of extracellular Zn
into dopaminergic neurons via AMPA receptor activation, which is initially induced by PQ-mediated ROS production in the SNpc, induces nigrostriatal dopaminergic degeneration, resulting in PQ-induced PD in rats. Intracellular Zn
dysregulation in dopaminergic neurons is the cause of PQ-induced pathogenesis in the SNpc, and the block of intracellular Zn
toxicity leads to defending PQ-induced pathogenesis. |
format | Article |
fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_30341553</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>30341553</sourcerecordid><originalsourceid>FETCH-pubmed_primary_303415533</originalsourceid><addsrcrecordid>eNqFTstqAkEQHAISTeIvhL55CAv7iGiuiQa9qARPXqQz0yujszOb7h3RL8hvZ4V49lTUg6q6U71sOHxLsmycd9WDyD5N8zxLR_eqW6TFa2sWPfX77oI-oCEIJXxhbQ3Mfeni6cKnp4ZRk3PRIcPGQ_4C1jcBFnbH6GASaqysJ95ZDQuKHLzA8kisQ0UCK2T8idgkc2-iJnMRDtZL8AOBiRVCobavnW3kSXVKdEL9f3xUz5_T9ccsqeN3RWZbs62Qz9vr8-Jm4A-aB0-J</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Blockade of Rapid Influx of Extracellular Zn 2+ into Nigral Dopaminergic Neurons Overcomes Paraquat-Induced Parkinson's Disease in Rats</title><source>MEDLINE</source><source>SpringerNature Complete Journals</source><creator>Tamano, Haruna ; Morioka, Hiroki ; Nishio, Ryusuke ; Takeuchi, Azusa ; Takeda, Atsushi</creator><creatorcontrib>Tamano, Haruna ; Morioka, Hiroki ; Nishio, Ryusuke ; Takeuchi, Azusa ; Takeda, Atsushi</creatorcontrib><description>The herbicide paraquat (PQ) has been reported to enhance the risk of developing Parkinson's disease (PD) from epidemiological studies. PQ-induced reactive oxygen species (ROS) are linked with a selective loss of nigrostriatal dopaminergic neurons. Here, we first report a unique mechanism of nigrostriatal dopaminergic degeneration, in which rapid intracellular Zn
dysregulation via PQ-induced ROS production causes PD in rats. When the substantia nigra pars compacta (SNpc) of rats was perfused with PQ, extracellular concentrations of glutamate and Zn
were increased and decreased, respectively, in the SNpc. These changes were ameliorated by co-perfusion with Trolox, an antioxidative agent. In in vitro slice experiments, PQ rapidly increased extracellular Zn
influx via AMPA receptor activation. Both loss of nigrostriatal dopaminergic neurons and increase in turning behavior in response to apomorphine were markedly reduced by coinjection of PQ and intracellular Zn
chelator, i.e., ZnAF-2DA into the SNpc. Furthermore, loss of nigrostriatal dopaminergic neurons induced with a low dose of PQ, which did not induce any behavioral abnormality, was completely blocked by coinjection of ZnAF-2DA. The present study indicates that rapid influx of extracellular Zn
into dopaminergic neurons via AMPA receptor activation, which is initially induced by PQ-mediated ROS production in the SNpc, induces nigrostriatal dopaminergic degeneration, resulting in PQ-induced PD in rats. Intracellular Zn
dysregulation in dopaminergic neurons is the cause of PQ-induced pathogenesis in the SNpc, and the block of intracellular Zn
toxicity leads to defending PQ-induced pathogenesis.</description><identifier>EISSN: 1559-1182</identifier><identifier>PMID: 30341553</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Behavior, Animal - drug effects ; Chelating Agents - pharmacology ; Chelating Agents - therapeutic use ; Dopaminergic Neurons - drug effects ; Dopaminergic Neurons - metabolism ; Dopaminergic Neurons - pathology ; Extracellular Space - metabolism ; Glutamic Acid - metabolism ; Male ; Models, Biological ; Movement Disorders - complications ; Movement Disorders - drug therapy ; Nerve Degeneration - drug therapy ; Nerve Degeneration - pathology ; Paraquat - toxicity ; Parkinson Disease - complications ; Parkinson Disease - drug therapy ; Parkinson Disease - metabolism ; Parkinson Disease - pathology ; Rats, Wistar ; Reactive Oxygen Species - metabolism ; Substantia Nigra - drug effects ; Substantia Nigra - pathology ; Zinc - metabolism</subject><ispartof>Molecular neurobiology, 2019-06, Vol.56 (6), p.4539</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0001-7519-2957</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30341553$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tamano, Haruna</creatorcontrib><creatorcontrib>Morioka, Hiroki</creatorcontrib><creatorcontrib>Nishio, Ryusuke</creatorcontrib><creatorcontrib>Takeuchi, Azusa</creatorcontrib><creatorcontrib>Takeda, Atsushi</creatorcontrib><title>Blockade of Rapid Influx of Extracellular Zn 2+ into Nigral Dopaminergic Neurons Overcomes Paraquat-Induced Parkinson's Disease in Rats</title><title>Molecular neurobiology</title><addtitle>Mol Neurobiol</addtitle><description>The herbicide paraquat (PQ) has been reported to enhance the risk of developing Parkinson's disease (PD) from epidemiological studies. PQ-induced reactive oxygen species (ROS) are linked with a selective loss of nigrostriatal dopaminergic neurons. Here, we first report a unique mechanism of nigrostriatal dopaminergic degeneration, in which rapid intracellular Zn
dysregulation via PQ-induced ROS production causes PD in rats. When the substantia nigra pars compacta (SNpc) of rats was perfused with PQ, extracellular concentrations of glutamate and Zn
were increased and decreased, respectively, in the SNpc. These changes were ameliorated by co-perfusion with Trolox, an antioxidative agent. In in vitro slice experiments, PQ rapidly increased extracellular Zn
influx via AMPA receptor activation. Both loss of nigrostriatal dopaminergic neurons and increase in turning behavior in response to apomorphine were markedly reduced by coinjection of PQ and intracellular Zn
chelator, i.e., ZnAF-2DA into the SNpc. Furthermore, loss of nigrostriatal dopaminergic neurons induced with a low dose of PQ, which did not induce any behavioral abnormality, was completely blocked by coinjection of ZnAF-2DA. The present study indicates that rapid influx of extracellular Zn
into dopaminergic neurons via AMPA receptor activation, which is initially induced by PQ-mediated ROS production in the SNpc, induces nigrostriatal dopaminergic degeneration, resulting in PQ-induced PD in rats. Intracellular Zn
dysregulation in dopaminergic neurons is the cause of PQ-induced pathogenesis in the SNpc, and the block of intracellular Zn
toxicity leads to defending PQ-induced pathogenesis.</description><subject>Animals</subject><subject>Behavior, Animal - drug effects</subject><subject>Chelating Agents - pharmacology</subject><subject>Chelating Agents - therapeutic use</subject><subject>Dopaminergic Neurons - drug effects</subject><subject>Dopaminergic Neurons - metabolism</subject><subject>Dopaminergic Neurons - pathology</subject><subject>Extracellular Space - metabolism</subject><subject>Glutamic Acid - metabolism</subject><subject>Male</subject><subject>Models, Biological</subject><subject>Movement Disorders - complications</subject><subject>Movement Disorders - drug therapy</subject><subject>Nerve Degeneration - drug therapy</subject><subject>Nerve Degeneration - pathology</subject><subject>Paraquat - toxicity</subject><subject>Parkinson Disease - complications</subject><subject>Parkinson Disease - drug therapy</subject><subject>Parkinson Disease - metabolism</subject><subject>Parkinson Disease - pathology</subject><subject>Rats, Wistar</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Substantia Nigra - drug effects</subject><subject>Substantia Nigra - pathology</subject><subject>Zinc - metabolism</subject><issn>1559-1182</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFTstqAkEQHAISTeIvhL55CAv7iGiuiQa9qARPXqQz0yujszOb7h3RL8hvZ4V49lTUg6q6U71sOHxLsmycd9WDyD5N8zxLR_eqW6TFa2sWPfX77oI-oCEIJXxhbQ3Mfeni6cKnp4ZRk3PRIcPGQ_4C1jcBFnbH6GASaqysJ95ZDQuKHLzA8kisQ0UCK2T8idgkc2-iJnMRDtZL8AOBiRVCobavnW3kSXVKdEL9f3xUz5_T9ccsqeN3RWZbs62Qz9vr8-Jm4A-aB0-J</recordid><startdate>201906</startdate><enddate>201906</enddate><creator>Tamano, Haruna</creator><creator>Morioka, Hiroki</creator><creator>Nishio, Ryusuke</creator><creator>Takeuchi, Azusa</creator><creator>Takeda, Atsushi</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><orcidid>https://orcid.org/0000-0001-7519-2957</orcidid></search><sort><creationdate>201906</creationdate><title>Blockade of Rapid Influx of Extracellular Zn 2+ into Nigral Dopaminergic Neurons Overcomes Paraquat-Induced Parkinson's Disease in Rats</title><author>Tamano, Haruna ; Morioka, Hiroki ; Nishio, Ryusuke ; Takeuchi, Azusa ; Takeda, Atsushi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_303415533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Behavior, Animal - drug effects</topic><topic>Chelating Agents - pharmacology</topic><topic>Chelating Agents - therapeutic use</topic><topic>Dopaminergic Neurons - drug effects</topic><topic>Dopaminergic Neurons - metabolism</topic><topic>Dopaminergic Neurons - pathology</topic><topic>Extracellular Space - metabolism</topic><topic>Glutamic Acid - metabolism</topic><topic>Male</topic><topic>Models, Biological</topic><topic>Movement Disorders - complications</topic><topic>Movement Disorders - drug therapy</topic><topic>Nerve Degeneration - drug therapy</topic><topic>Nerve Degeneration - pathology</topic><topic>Paraquat - toxicity</topic><topic>Parkinson Disease - complications</topic><topic>Parkinson Disease - drug therapy</topic><topic>Parkinson Disease - metabolism</topic><topic>Parkinson Disease - pathology</topic><topic>Rats, Wistar</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Substantia Nigra - drug effects</topic><topic>Substantia Nigra - pathology</topic><topic>Zinc - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tamano, Haruna</creatorcontrib><creatorcontrib>Morioka, Hiroki</creatorcontrib><creatorcontrib>Nishio, Ryusuke</creatorcontrib><creatorcontrib>Takeuchi, Azusa</creatorcontrib><creatorcontrib>Takeda, Atsushi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Molecular neurobiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tamano, Haruna</au><au>Morioka, Hiroki</au><au>Nishio, Ryusuke</au><au>Takeuchi, Azusa</au><au>Takeda, Atsushi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Blockade of Rapid Influx of Extracellular Zn 2+ into Nigral Dopaminergic Neurons Overcomes Paraquat-Induced Parkinson's Disease in Rats</atitle><jtitle>Molecular neurobiology</jtitle><addtitle>Mol Neurobiol</addtitle><date>2019-06</date><risdate>2019</risdate><volume>56</volume><issue>6</issue><spage>4539</spage><pages>4539-</pages><eissn>1559-1182</eissn><abstract>The herbicide paraquat (PQ) has been reported to enhance the risk of developing Parkinson's disease (PD) from epidemiological studies. PQ-induced reactive oxygen species (ROS) are linked with a selective loss of nigrostriatal dopaminergic neurons. Here, we first report a unique mechanism of nigrostriatal dopaminergic degeneration, in which rapid intracellular Zn
dysregulation via PQ-induced ROS production causes PD in rats. When the substantia nigra pars compacta (SNpc) of rats was perfused with PQ, extracellular concentrations of glutamate and Zn
were increased and decreased, respectively, in the SNpc. These changes were ameliorated by co-perfusion with Trolox, an antioxidative agent. In in vitro slice experiments, PQ rapidly increased extracellular Zn
influx via AMPA receptor activation. Both loss of nigrostriatal dopaminergic neurons and increase in turning behavior in response to apomorphine were markedly reduced by coinjection of PQ and intracellular Zn
chelator, i.e., ZnAF-2DA into the SNpc. Furthermore, loss of nigrostriatal dopaminergic neurons induced with a low dose of PQ, which did not induce any behavioral abnormality, was completely blocked by coinjection of ZnAF-2DA. The present study indicates that rapid influx of extracellular Zn
into dopaminergic neurons via AMPA receptor activation, which is initially induced by PQ-mediated ROS production in the SNpc, induces nigrostriatal dopaminergic degeneration, resulting in PQ-induced PD in rats. Intracellular Zn
dysregulation in dopaminergic neurons is the cause of PQ-induced pathogenesis in the SNpc, and the block of intracellular Zn
toxicity leads to defending PQ-induced pathogenesis.</abstract><cop>United States</cop><pmid>30341553</pmid><orcidid>https://orcid.org/0000-0001-7519-2957</orcidid></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1559-1182 |
ispartof | Molecular neurobiology, 2019-06, Vol.56 (6), p.4539 |
issn | 1559-1182 |
language | eng |
recordid | cdi_pubmed_primary_30341553 |
source | MEDLINE; SpringerNature Complete Journals |
subjects | Animals Behavior, Animal - drug effects Chelating Agents - pharmacology Chelating Agents - therapeutic use Dopaminergic Neurons - drug effects Dopaminergic Neurons - metabolism Dopaminergic Neurons - pathology Extracellular Space - metabolism Glutamic Acid - metabolism Male Models, Biological Movement Disorders - complications Movement Disorders - drug therapy Nerve Degeneration - drug therapy Nerve Degeneration - pathology Paraquat - toxicity Parkinson Disease - complications Parkinson Disease - drug therapy Parkinson Disease - metabolism Parkinson Disease - pathology Rats, Wistar Reactive Oxygen Species - metabolism Substantia Nigra - drug effects Substantia Nigra - pathology Zinc - metabolism |
title | Blockade of Rapid Influx of Extracellular Zn 2+ into Nigral Dopaminergic Neurons Overcomes Paraquat-Induced Parkinson's Disease in Rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T05%3A13%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Blockade%20of%20Rapid%20Influx%20of%20Extracellular%20Zn%202+%20into%20Nigral%20Dopaminergic%20Neurons%20Overcomes%20Paraquat-Induced%20Parkinson's%20Disease%20in%20Rats&rft.jtitle=Molecular%20neurobiology&rft.au=Tamano,%20Haruna&rft.date=2019-06&rft.volume=56&rft.issue=6&rft.spage=4539&rft.pages=4539-&rft.eissn=1559-1182&rft_id=info:doi/&rft_dat=%3Cpubmed%3E30341553%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/30341553&rfr_iscdi=true |